非血管用ステント市場：製品タイプ、材料タイプ、エンドユーザー別-2025～2030年の世界予測

非血管用ステント市場は、2023年に12億1,000万米ドルと評価され、2024年には13億米ドルに達すると予測され、CAGR 7.25％で成長し、2030年には19億8,000万米ドルになると予測されています。

非血管用ステントは、気管、気管支、食道、胆道、尿管など、血管系に属さない体内の通路を支え、開くために使用される医療機器です。その範囲は、消化器内科、呼吸器内科、泌尿器科など、さまざまな医学分野に及んでいます。非血管用ステントの必要性は、腫瘍や解剖学的異常による閉塞のような状態から生じ、身体の通路の開通を維持することで重要な緩和をもたらします。その用途は、特にがんや慢性疾患の患者の症状を緩和し、合併症を減らし、生活の質を向上させるために、重要な通路に挿入することに及ぶ。これらの器具の最終使用範囲は、主に病院、専門クリニック、外来手術センターです。

市場の洞察によると、非血管ステント留置を必要とする疾患の有病率の増加と、ステント材料と設計を改善する医療技術の進歩が成長軌道の原動力となっています。生分解性ステントや薬剤溶出性ステントの技術革新により、患者の予後を改善し合併症を減らすことができるため、この市場のビジネスチャンスが活用される可能性があります。新興市場への地理的拡大も、これらの地域におけるヘルスケア・インフラと患者の意識の高まりを考えれば、可能性があります。しかし、ステント治療の高額な費用、ステントの移動・閉塞などの合併症の可能性、製品発売を遅らせる規制上の課題などの制約があります。さらに、競合情勢は厳しく、主要企業は市場シェアを維持するために継続的な技術革新を必要としています。

技術革新の展望は、高度な画像処理技術と3Dプリンティング技術を駆使した個別化ステント・ソリューションの開発にあり、これによってオーダーメイドの介入と有効性の向上が期待できます。同市場は、技術の進歩、規制状況、進化する患者の需要に影響され、緩やかな成長傾向を示しています。事業成長のためには、技術共有のための戦略的パートナーシップに注力し、複雑な規制を効果的に乗り切ることが重要です。ステントのデザインと機能性を向上させながら、コストを削減し、アクセシビリティを高めるための継続的な研究開発は、このダイナミックな市場において企業を有利に位置づけると思われます。

市場力学：急速に進化する非血管用ステント市場の主要市場インサイトを解明

非血管用ステント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 消化器がんの有病率の増加
  • 泌尿器疾患および肺疾患の発生率の増加
  • 老年人口の増加と慢性疾患の蔓延
• 市場抑制要因
  • 管腔粘膜の刺激や再狭窄の発生など、従来のベアステントにおける合併症
• 市場機会
  • 生分解性ポリマーや生体吸収性ステントの開発が精力的に行われています。
  • 眼科用や神経用などの新しい応用分野
• 市場の課題
  • 血管形成術の合併症に関する懸念の増大

ポーターの5つの力：非血管用ステント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：非血管用ステント市場における外部からの影響の把握

外部マクロ環境要因は、非血管用ステント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析非血管用ステント市場における競合情勢の把握

非血管用ステント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス非血管用ステント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、非血管用ステント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨非血管用ステント市場における成功への道筋を描く

非血管用ステント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 消化器がんの罹患率の増加
    • 泌尿器および肺疾患の発生率増加
    • 高齢者人口の増加と慢性疾患の蔓延
  • 抑制要因
    • 従来のベアステントでは、内腔粘膜を刺激し、再狭窄を引き起こすなどの合併症が発生します。
  • 機会
    • 生分解性ポリマーと生体吸収性ステントの徹底的な開発
    • 眼科や神経系への応用などの新たな応用分野
  • 課題
    • 血管形成術の合併症に関する懸念の高まり
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 非血管用ステント市場：製品別

• 消化管ステント
  • 胆管ステント
  • 結腸ステント
  • 十二指腸ステント
  • 食道ステント
  • 膵臓ステント
• 肺ステント
  • 金属製気道ステント
  • シリコン気道ステント
• 泌尿器科用ステント

第7章 非血管用ステント市場素材タイプ別

• 金属ステント
• 非金属ステント

第8章 非血管用ステント市場：エンドユーザー別

• 外来手術センター
• 病院

第9章 南北アメリカの非血管用ステント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の非血管用ステント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの非血管用ステント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Becton, Dickinson and Company
• Boston Scientific Corporation
• CONMED Corporation
• Cook Group Incorporated
• ELLA-CS, Ltd.
• GE Healthcare
• Glaukos Corporation
• Hobbs Medical Inc.
• Medtronic PLC
• Micro-Tech（Nanjing）Co., Ltd.
• Olympus Corporation
• PENTAX Europe GmbH
• Synchron Med Inc.
• Taewoong Medical Co., Ltd.
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. NON-VASCULAR STENTS MARKET RESEARCH PROCESS
• FIGURE 2. NON-VASCULAR STENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NON-VASCULAR STENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NON-VASCULAR STENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NON-VASCULAR STENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NON-VASCULAR STENTS MARKET DYNAMICS
• TABLE 7. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLONIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PANCREATIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY METALLIC AIRWAY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SILICONE AIRWAY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NON-METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. CANADA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. CANADA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 45. CANADA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. CHINA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 72. CHINA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. INDIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. INDIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 77. INDIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ITALY NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. ITALY NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 163. ITALY NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. POLAND NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. POLAND NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 183. POLAND NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. QATAR NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. QATAR NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 188. QATAR NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY PULMONARY STENTS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. NON-VASCULAR STENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. NON-VASCULAR STENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Non-vascular Stents Market was valued at USD 1.21 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 7.25%, to USD 1.98 billion by 2030.

Non-vascular stents are medical devices used to support and open passages in the body that are not part of the vascular system, such as the trachea, bronchi, esophagus, biliary duct, and ureter. This scope extends across various fields of medicine, including gastroenterology, pulmonology, and urology. The necessity of non-vascular stents arises from conditions like obstructions due to tumors or anatomical abnormalities, where they provide critical relief by maintaining patency in bodily passageways. Their application spans the insertion into critical passages to alleviate symptoms, reduce complications, and improve quality of life, particularly for patients with cancer or chronic conditions. The end-use scope of these devices predominantly involves hospitals, specialized clinics, and outpatient surgical centers.

Market insights suggest a growth trajectory driven by the increasing prevalence of diseases necessitating non-vascular stent placement and advancements in medical technology that improve stent materials and designs. Opportunities in this market could be leveraged through innovations in biodegradable stents and drug-eluting stents, which can enhance patient outcomes and reduce complications. Geographical expansions into emerging markets also offer potential, given the rising healthcare infrastructure and patient awareness in these regions. However, limitations include the high cost of stent procedures, potential complications such as migration or obstruction of stents, and regulatory challenges that can delay product launches. Furthermore, the competitive landscape is challenging, with key players needing to continually innovate to maintain market share.

Innovation prospects lie in developing personalized stent solutions using advanced imaging and 3D printing technologies, which can promise tailored interventions and improved efficacy. The market reveals a moderate growth nature, influenced by technological advancement, regulatory landscapes, and evolving patient demands. For business growth, focusing on strategic partnerships for technology sharing and navigating regulatory complexities effectively will be crucial. Continuous research and development to improve stent design and functionality while reducing cost and enhancing accessibility will position companies advantageously in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-vascular Stents Market

The Non-vascular Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of gastrointestinal cancer
  • Growing incidence of urological and pulmonary disorder
  • Rising geriatric population & prevalence of chronic disorders
• Market Restraints
  • Complications in conventional bare stents such as irritate luminal mucosa and produce restenosis
• Market Opportunities
  • Rigourous development in biodegradable polymers and bio-absorbable stent
  • Emerging applications areas such as ophthalmic and neural applications
• Market Challenges
  • Increasing concern associated with complication of angioplasty

Porter's Five Forces: A Strategic Tool for Navigating the Non-vascular Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-vascular Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-vascular Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-vascular Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-vascular Stents Market

A detailed market share analysis in the Non-vascular Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-vascular Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-vascular Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-vascular Stents Market

A strategic analysis of the Non-vascular Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-vascular Stents Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, ELLA-CS, Ltd., GE Healthcare, Glaukos Corporation, Hobbs Medical Inc., Medtronic PLC, Micro-Tech (Nanjing) Co., Ltd., Olympus Corporation, PENTAX Europe GmbH, Synchron Med Inc., Taewoong Medical Co., Ltd., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Non-vascular Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Gastrointestinal Stents, Pulmonary Stents, and Urological Stents. The Gastrointestinal Stents is further studied across Biliary Stents, Colonic Stents, Duodenal Stents, Esophageal Stents, and Pancreatic Stents. The Pulmonary Stents is further studied across Metallic Airway Stents and Silicone Airway Stents.
• Based on Material Type, market is studied across Metallic Stents and Non-Metallic Stents.
• Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of gastrointestinal cancer
    • 5.1.1.2. Growing incidence of urological and pulmonary disorder
    • 5.1.1.3. Rising geriatric population & prevalence of chronic disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Complications in conventional bare stents such as irritate luminal mucosa and produce restenosis
  • 5.1.3. Opportunities
    • 5.1.3.1. Rigourous development in biodegradable polymers and bio-absorbable stent
    • 5.1.3.2. Emerging applications areas such as ophthalmic and neural applications
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing concern associated with complication of angioplasty
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Non-vascular Stents Market, by Product

• 6.1. Introduction
• 6.2. Gastrointestinal Stents
  • 6.2.1. Biliary Stents
  • 6.2.2. Colonic Stents
  • 6.2.3. Duodenal Stents
  • 6.2.4. Esophageal Stents
  • 6.2.5. Pancreatic Stents
• 6.3. Pulmonary Stents
  • 6.3.1. Metallic Airway Stents
  • 6.3.2. Silicone Airway Stents
• 6.4. Urological Stents

7. Non-vascular Stents Market, by Material Type

• 7.1. Introduction
• 7.2. Metallic Stents
• 7.3. Non-Metallic Stents

8. Non-vascular Stents Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals

9. Americas Non-vascular Stents Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Non-vascular Stents Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Non-vascular Stents Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Boston Scientific Corporation
• 3. CONMED Corporation
• 4. Cook Group Incorporated
• 5. ELLA-CS, Ltd.
• 6. GE Healthcare
• 7. Glaukos Corporation
• 8. Hobbs Medical Inc.
• 9. Medtronic PLC
• 10. Micro-Tech (Nanjing) Co., Ltd.
• 11. Olympus Corporation
• 12. PENTAX Europe GmbH
• 13. Synchron Med Inc.
• 14. Taewoong Medical Co., Ltd.
• 15. W. L. Gore & Associates, Inc.